Agilon Health Inc [NYSE: AGL] price surged by 0.83 percent to reach at $0.01.
A sum of 7747048 shares traded at recent session while its average daily volume was at 9.42M shares. Agilon Health Inc shares reached a high of $1.26 and dropped to a low of $1.15 until finishing in the latest session at $1.21.
The one-year AGL stock forecast points to a potential upside of 5.47. The average equity rating for AGL stock is currently 3.05, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on Agilon Health Inc [AGL]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AGL shares is $1.28 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AGL stock is a recommendation set at 3.05. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Bernstein have made an estimate for Agilon Health Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on August 20, 2025. The new note on the price target was released on August 06, 2025, representing the official price target for Agilon Health Inc stock. Previously, the target price had yet another raise to $5, while Citigroup analysts kept a Buy rating on AGL stock.
The Price to Book ratio for the last quarter was 1.23, with the Price to Cash per share for the same quarter was set at 0.79.
AGL Stock Performance Analysis:
Agilon Health Inc [AGL] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -6.92. With this latest performance, AGL shares gained by 37.48% in over the last four-week period, additionally sinking by -65.82% over the last 6 months – not to mention a drop of -36.32% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AGL stock in for the last two-week period is set at 40.64, with the RSI for the last a single of trading hit 0.1138, and the three-weeks RSI is set at 0.1367 for Agilon Health Inc [AGL]. The present Moving Average for the last 50 days of trading for this stock 1.7102, while it was recorded at 1.2460 for the last single week of trading, and 2.7384 for the last 200 days.
Insight into Agilon Health Inc Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Agilon Health Inc [AGL] shares currently have an operating margin of -6.34% and a Gross Margin at -2.22%. Agilon Health Inc’s Net Margin is presently recorded at -5.57%.
Agilon Health Inc (AGL) Capital Structure & Debt Analysis
According to recent financial data for Agilon Health Inc. ( AGL), the Return on Equity (ROE) stands at -60.64%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -16.98%, reflecting the company’s efficiency in generating profits from its assets. Additionally, Agilon Health Inc’s Return on Invested Capital (ROIC) is -79.08%, showcasing its effectiveness in deploying capital for earnings.
Agilon Health Inc (AGL) Efficiency & Liquidity Metrics
Based on Agilon Health Inc’s (AGL) latest financial statements, the Debt-to-Equity Ratio is 0.10%, indicating its reliance on debt financing relative to shareholder equity.
Agilon Health Inc (AGL) Efficiency & Liquidity Metrics
From an operational efficiency perspective, Agilon Health Inc. (AGL) effectively leverages its workforce, generating an average of -$305278.81 per employee. The company’s liquidity position is robust, with a Current Ratio of 1.16% and a Quick Ratio of 1.16%, indicating strong ability to cover short-term liabilities.
AGL Stock EPS
With the latest financial reports released by the company, Agilon Health Inc posted -0.28/share EPS, while the average EPS was predicted by analysts to be reported at -0.09/share. When compared, the two values demonstrate that the company fail the estimates by a Surprise Factor of -0.19. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AGL. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Agilon Health Inc go to 28.30%.
Agilon Health Inc [AGL] Institutonal Ownership Details
There are presently around $101.74%, or 103.91%% of AGL stock, in the hands of institutional investors. The top three institutional holders of AGL stocks are: CLAYTON, DUBILIER & RICE, LLC with ownership of 100.0 million shares, which is approximately 24.3149%. FMR LLC, holding 56.93 million shares of the stock with an approximate value of $$372.3 million in AGL stocks shares; and FMR LLC, currently with $$368.94 million in AGL stock with ownership which is approximately 13.7168%.
